within Pharmacolibrary.Drugs.ATC.B;

model B05XX02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.08333333333333333,
    adminDuration  = 600,
    adminMass      = 5.0,
    adminCount     = 1,
    Vd             = 0.0003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Trometamol (also known as tromethamine or tris(hydroxymethyl)aminomethane) is an organic amine proton acceptor used as a systemic alkalizer, especially for the correction of metabolic acidosis. It is primarily utilized in critical care settings to manage severe metabolic acidosis, especially when the use of sodium bicarbonate is contraindicated or ineffective. It is not widely used outside hospital or intensive care and is not approved as a routine therapy in most countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult subjects, since direct human PK data are scarce or not explicitly reported in accessible publications. Estimates generally based on analogous buffer agents and limited references in critical care settings.</p><h4>References</h4><ol><li><p>Wu, M, et al., &amp; Ding, Y (2020). Pharmacokinetics, Safety, and Tolerability of Intravenous Felbinac Trometamol in Healthy Chinese Volunteers: A First-in-Human Single- and Multiple-Dose Escalation Phase I Study with a Randomized, Double-Blind, Placebo-Controlled Design. <i>CNS drugs</i> 34(8) 867–877. DOI:<a href=&quot;https://doi.org/10.1007/s40263-020-00739-z&quot;>10.1007/s40263-020-00739-z</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32700191/&quot;>https://pubmed.ncbi.nlm.nih.gov/32700191</a></p></li><li><p>Zhang, C, et al., &amp; Wang, W (2011). Pharmacokinetics of felbinac after intravenous administration of felbinac trometamol in rats. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 41(4) 340–348. DOI:<a href=&quot;https://doi.org/10.3109/00498254.2010.544422&quot;>10.3109/00498254.2010.544422</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21182394/&quot;>https://pubmed.ncbi.nlm.nih.gov/21182394</a></p></li><li><p>Villa, R, et al., &amp; Cagnardi, P (2015). Pharmacokinetics of intravenous ketorolac in cats undergoing gonadectomy. <i>New Zealand veterinary journal</i> 63(3) 162–166. DOI:<a href=&quot;https://doi.org/10.1080/00480169.2014.987329&quot;>10.1080/00480169.2014.987329</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25523103/&quot;>https://pubmed.ncbi.nlm.nih.gov/25523103</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B05XX02;
